Skip to main content

Table 1 Patient, healthcare and total median delay, interquartile range (IQR) and logrank test (p-value) by clinical and sociodemographic variables

From: Delayed diagnosis of active pulmonary tuberculosis - potential risk factors for patient and healthcare delays in Portugal

Variables

Patients

Patient delay

Healthcare delay

Total delay

n/N (%)

Median (IQR) (days)

Logrank (p-value)

Median (IQR) (days)

Logrank (p-value)

Median (IQR) (days)

Logrank (p-value)

Sex

  

0,395

 

< 0,001

 

< 0,001

 Male

8281/11762 (70.4%)

37 (19–71)

 

7 (1–30)

 

61 (37–100)

 

 Female

3481/11762 (29.6%)

36 (19–70)

 

11 (2–39)

 

66 (40–106)

 

Age

  

< 0,001

 

< 0,001

 

< 0,001

 0–4 years

50/11750 (0.4%)

25.5 (17–49)

 

10.5 (4–44)

 

47 (32.5–95)

 

 5–14 years

73/11750 (0.6%)

33 (18–70)

 

7 (2–21.5)

 

52 (32–88)

 

 15–24 years

1109/11750 (9.4%)

36 (20–65)

 

6 (1–22)

 

55 (34–83)

 

 25–34 years

1951/11750 (16.6%)

39 (21–74)

 

7 (1–25)

 

59 (37–97)

 

 35–44 years

2682/11750 (22.8%)

38 (19–74)

 

6.5 (1–27)

 

60 (36–99)

 

 45–54 years

2430/11750 (20.7%)

40 (20–75)

 

7 (1–28)

 

64.5 (38–106)

 

 55–64 years

1464/11750 (12.4%)

38 (20–75)

 

10 (1–36)

 

68 (40–109)

 

 > = 65 years

1991/11750 (16.9%)

30 (14–60)

 

21 (4–55)

 

70 (41–112)

 

Country of origin

  

< 0,001

 

0.002

 

0.033

 Portugal

9901/11747 (84.2)

36 (18–69)

 

9 (1–33)

 

62 (37–102)

 

 Country of high TB incidence

1752/11747 (14.9)

44 (24–80)

 

7 (1–27)

 

66,5 (41–106)

 

 Country of low TB incidence

94/11747 (0.8)

34.5 (18–64)

 

8 (1–28)

 

59 (31–99)

 

Comorbidities

 Chronic renal failure

100/11762 (0.9%)

 

< 0,001

 

0,013

 

0,316

 Yes

 

24 (9–42)

 

21 (4–46)

 

52 (26–87)

 

 No

 

37 (19–71)

 

8 (1–32)

 

62 (38–102)

 

 Oncologic diseases

488/11762 (4.1%)

 

0,001

 

< 0,001

 

0,048

 Yes

 

30 (15–55)

 

26 (5–55)

 

66 (42–108)

 

 No

 

37 (19–72)

 

8 (1–31)

 

62 (37–102)

 

 Inflammatory diseases

107/11572 (0.9%)

 

0,414

 

0,036

 

0,04

 Yes

 

32 (16–83)

 

16 (2–48)

 

79 (42–117)

 

 No

 

37 (19–71)

 

8 (1–33)

 

62 (38–102)

 

 Respiratory diseases

647/11762 (5.5%)

 

0,231

 

< 0,001

 

0,004

 Yes

 

33 (14–69)

 

13 (2–46)

 

70 (40–113)

 

 No

 

37 (19–71)

 

8 (1–32)

 

62 (37–102)

 

 Diabetes

780/11762 (6.6%)

 

0,929

 

0,003

 

0,087

 Yes

 

38 (19–73)

 

11 (2–39)

 

68 (41–111)

 

 No

 

37 (19–71)

 

8 (1–32)

 

62 (37–102)

 

 HIV infection

1240/10793 (11.5%)

 

< 0,001

 

< 0,001

 

< 0,001

 Yes

 

36 (19–64)

 

8 (1–27)

 

56 (35–89)

 

 No

 

38 (19–73)

 

8 (1–33)

 

64 (38–105)

 

Substance abuse

 Alcohol abuse

1832/11270 (16.3%)

 

< 0,001

 

< 0,001

 

0,699

 Yes

 

43 (22–81)

 

5 (1–21)

 

62.5 (36–103)

 

 No

 

36 (18–68)

 

9 (1–35)

 

62 (38–102)

 

 Drug abuse

1234/11363 (10.9%)

 

0,421

 

< 0,001

 

0,001

 Yes

 

38 (19–74)

 

5 (1–23)

 

57 (34–95)

 

 No

 

37 (19–70)

 

9 (1–34)

 

63 (38–103)

 

Homeless

201/11518 (1.7%)

 

0,745

 

< 0,001

 

0,001

 Yes

 

39 (20–76)

 

4 (1–20)

 

54 (29–90)

 

 No

 

37 (19–71)

 

8 (1–33)

 

63 (38–103)

 

Community residence

366/11479 (3.2%)

 

0,099

 

0,001

 

< 0,001

 Yes

 

33 (19–60)

 

6 (1–22)

 

53 (33–86)

 

 No

 

37 (19–72)

 

8 (1–33)

 

63 (38–103)

 

Unemployment

1891/11762 (16.1%)

 

< 0,001

 

< 0,001

 

0,357

 Yes

 

42 (21–79)

 

5 (1–22)

 

61 (36–100)

 

 No

 

36 (18–70)

 

9 (1–34)

 

62 (38–103)

 

Health professional

463/11762 (3.9%)

 

0,001

 

0,69

 

0,024

 Yes

 

30 (16–59)

 

9 (1–33)

 

57 (31–98)

 

 No

 

37 (19–72)

 

8 (1–32)

 

62 (38–102)

 
  1. IQR interquartile range (Q1-Q3)